摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

乙基 3-氨基肉桂酸 | 6328-01-4

中文名称
乙基 3-氨基肉桂酸
中文别名
乙基3-氨基肉桂酸
英文名称
ethyl 3-(3-aminophenyl)acrylate
英文别名
m-Aminozimtsaeureethylester;3-amino-cinnamic acid ethyl ester;3-Amino-zimtsaeure-aethylester;3-(3-amino-phenyl)-acrylic acid ethyl ester;Ethyl-3-aminocinnamate;ethyl 3-(3-aminophenyl)prop-2-enoate
乙基 3-氨基肉桂酸化学式
CAS
6328-01-4
化学式
C11H13NO2
mdl
——
分子量
191.23
InChiKey
UEUURYZTMLPUEE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    348.3±25.0 °C(Predicted)
  • 密度:
    1.130±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    52.3
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:5c5c76f513fae25e5f7d520acac9c5d8
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    乙基 3-氨基肉桂酸氯仿 作用下, 生成 3-(3-amino-2,4,6-tribromo-phenyl)-2,3-dibromo-propionic acid ethyl ester
    参考文献:
    名称:
    Underwood; Kochmann, Journal of the American Chemical Society, 1926, vol. 48, p. 255
    摘要:
    DOI:
  • 作为产物:
    描述:
    3-硝基肉桂酸乙酯 在 tin(II) chloride dihdyrate 、 乙醇 作用下, 反应 2.0h, 生成 乙基 3-氨基肉桂酸
    参考文献:
    名称:
    EP2 RECEPTOR AGONISTS
    摘要:
    公式(III)的化合物:或其盐、溶剂合物和化学保护形式,其中:R5是可选择取代的C5-20芳基或C4-20烷基基团;L′是单键,—O—或—C(═O)—;A选自以下组:式(i)(ii)(iii),其中X和Y选自以下组:O和CR3;S和CR3;NH和CR3;NH和N;O和N;S和N;N和S;和N和O,其中虚线表示适当位置的双键,Q是N或CH;D从以下中选择:式(i)(ii)(iii)(iv)(v)(vii)(viii)(ix)B从以下组中选择:式(A)(B),其中RP6选自氟和氯;R2是:(i)—CO2H;(ii)—CONH2;(iii)—CH2—OH;或(iv)四唑-5-基。
    公开号:
    US20100130556A1
点击查看最新优质反应信息

文献信息

  • Oxidation and Resulting Mechanical Properties of Ni/8Y<sub>2</sub>O<sub>3</sub>-stabilized Zirconia Anode Substrate for Solid-oxide Fuel Cells
    作者:George Stathis、Dimitrios Simwonis、Frank Tietz、Antonia Moropoulou、Aristides Naoumides
    DOI:10.1557/jmr.2002.0142
    日期:2002.5

    Ni/8 mol% Y2O3-stabilized zirconia cermets are used in thin-film electrolyte solid-oxide fuel cells as support substrates. Rapid oxidation of the metallic Ni can cause failure of the substrate and of the whole system. The rate of Ni oxidation in air and in an inert atmosphere containing water vapor was determined as a function of temperature between 500 and 950 °C. A logarithmic rate law describes the oxidation kinetics in air, whereas a linear rate law fits the first branch of the curve of the experimental data in a humidified inert atmosphere. The substrate exhibits no significant mechanical degradation after uniform oxidation under moderate conditions. However, the observed bending of the samples after oxidation in humidified argon, due to the nonuniform oxidation, can cause damage to fuel cell

    在薄膜电解质固态氧化物燃料电池中,镍/8 mol% Y2O3 稳定氧化锆金属陶瓷被用作支撑基板。金属镍的快速氧化会导致衬底和整个系统失效。我们测定了镍在空气和含有水蒸气的惰性气氛中的氧化速率与 500 至 950 °C 温度之间的函数关系。对数速率法则描述了空气中的氧化动力学,而线性速率法则则符合加湿惰性气氛中实验数据曲线的第一分支。在中等条件下均匀氧化后,基底没有出现明显的机械降解。但是,在加湿氩气中氧化后,由于氧化不均匀,观察到样品出现弯曲,这可能会对燃料电池造成损坏。
  • Novel, Cyclically Substituted Furopyrimidine Derivatives and Use Thereof
    申请人:Lampe Thomas
    公开号:US20110124665A1
    公开(公告)日:2011-05-26
    The present application relates to novel, cyclically substituted furopyrimidine derivatives, methods for their production, their use for the treatment and/or prophylaxis of diseases and their use for the production of medicinal products for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular diseases.
    本申请涉及新型的、环状取代的呋喃嘧啶衍生物,其生产方法,以及它们用于治疗和/或预防疾病的应用,特别用于治疗和/或预防心血管疾病的治疗和/或预防药物的生产。
  • [EN] EP2 RECEPTOR AGONISTS<br/>[FR] AGONISTES DES RECEPTEURS EP2
    申请人:PHARMAGENE LAB LTD
    公开号:WO2005080367A1
    公开(公告)日:2005-09-01
    A compound of Formula (I) or a salt, solvate and chemically protected form thereof, wherein: R5 is an optionally substituted C5-20 aryl or C4-20 alkyl group; A is selected from the group consisting of Formulae (Ai), (Aii), (Aiii) D is selected from Formulae (Di), (Dii), (Diii), (Div), (Dv) B is selected from the group consisting of Formulae (Bi), (Bii), (Biii), (Biv) (Bv).
    一个由化学式(I)或其盐、溶剂合物和化学保护形式组成的化合物,其中:R5是一个可选择取代的C5-20芳基或C4-20烷基基团;A选自由化合物(Ai)、(Aii)、(Aiii)组成的群;D选自由化合物(Di)、(Dii)、(Diii)、(Div)、(Dv)组成的群;B选自由化合物(Bi)、(Bii)、(Biii)、(Biv)、(Bv)组成的群。
  • [EN] E-ISOMERIC beta-AROMATIC OR HETEROAROMATIC SUBSTITUTED beta-ACYLAMINO-ACRYLATES AND METHODS OF PREPARING THE SAME<br/>[FR] DOLLAR G(B)-ACYLAMINO-ACRYLATES E-ISOMERES A SUBSTITUTION DOLLAR G(B)-AROMATIQUE OU HETEROAROMATIQUE ET LEUR PROCEDES DE PREPARATION
    申请人:DSM IP ASSETS BV
    公开号:WO2004011414A1
    公开(公告)日:2004-02-05
    E-isomeric ß-(hetero) aromatically substituted acylaminoacrylates are of great economic interest since with them, by means of hydration, precursors of appropriately substituted (ß-amino acids can be prepared and, by doing so, lead to higher enantio-selectivities than the corresponding Z-isomers. The invention describes novel E-isomeric R-aromatically or ß-heteroaromatically substituted ß-acylaminoacrylates of the general formula (I): in which R represents hydrogen or a substituted or unsubstituted alkyl or aromatic or heteroaromatic residue, and R' represents a substituted or unsubstituted aromatic or heteroaromatic residue, R' represents H, a substituted or unsubstituted alkyl or aromatic or heteroaromatic residue, and R'' represents H, a substituted or unsubstituted alkyl, acyl, aromatic or heteroaromatic residue. According to the invention, the compounds according to the general formula (I) are prepared by acylation at temperatures below the boiling point of the reaction mixture.
    E-异构体ß-(杂)芳基取代的酰胺基丙烯酸酯具有巨大的经济价值,因为通过水合作用,可以制备适当取代的(ß-氨基酸的前体,并且通过这种方式,可以实现比相应的Z-异构体更高的对映选择性。该发明描述了一种新颖的E-异构体R-芳基或ß-杂芳基取代的ß-酰胺基丙烯酸酯,其一般式为(I):其中R代表氢或取代或未取代的烷基或芳基或杂芳基残基,R'代表取代或未取代的芳基或杂芳基残基,R''代表氢,取代或未取代的烷基或芳基或杂芳基残基。根据该发明,按照一般式(I)的化合物是通过在低于反应混合物沸点的温度下进行酰化制备的。
  • [EN] ANTICANCER AGENTS<br/>[FR] AGENTS ANTICANCÉREUX
    申请人:UNIV MINNESOTA
    公开号:WO2009018344A1
    公开(公告)日:2009-02-05
    The invention provides a compound of the invention, which is a compound of formula A-X-L-B, or a salt thereof, as well as compositions comprising a compound of the invention, and therapeutic methods that include the administration of a compound of the invention. The compounds of the invention are useful as therapeutic agents for the treatment of diseases such as cancer.
    该发明提供了一种该发明的化合物,该化合物为A-X-L-B式的化合物或其盐,以及包含该发明的化合物的组合物,以及包括给予该发明的化合物的治疗方法。该发明的化合物可用作治疗剂,用于治疗癌症等疾病。
查看更多